Evidence map›Paper›PMID 40991091›Full record

ArticleAntonie van Leeuwenhoek2025

Pseudomonas gelidaquae sp. nov., an Antarctic bacterium with a distinctive Type III Secretion System, isolated from Fildes Bay, King George Island.

Sebastián Higuera-Llantén, María S Pavlov, Leandro P de Sousa, Felipe Vásquez-Ponce, Juan Parás-Silva, José R W Martínez, José M Munita, Aniela Wozniak, Patricia C García, Juan A Ugalde and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Antonie van Leeuwenhoek, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. From genome to lifestyle: adaptive strategies ofApplied and environmental microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sebastián Higuera-Llantén *Grupo de Resistencia Antimicrobiana en Bacterias Patógenas y Ambientales, GRABPA, Instituto de Biología, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
María S Pavlov *Grupo de Resistencia Antimicrobiana en Bacterias Patógenas y Ambientales, GRABPA, Instituto de Biología, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Leandro P de SousaCentro de Pesquisa e Desenvolvimento de Recursos Genéticos Vegetais, Instituto Agronômico, Campinas, Sao Paulo, Brazil.
Felipe Vásquez-PonceGrupo de Resistencia Antimicrobiana en Bacterias Patógenas y Ambientales, GRABPA, Instituto de Biología, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Juan Parás-SilvaGrupo de Resistencia Antimicrobiana en Bacterias Patógenas y Ambientales, GRABPA, Instituto de Biología, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
José R W MartínezIniciativa Científica Milenio Para la Investigación Asociativa en Resistencia Antimicrobiana, MICROB-R, Santiago, Chile.
José M MunitaIniciativa Científica Milenio Para la Investigación Asociativa en Resistencia Antimicrobiana, MICROB-R, Santiago, Chile.
Aniela WozniakIniciativa Científica Milenio Para la Investigación Asociativa en Resistencia Antimicrobiana, MICROB-R, Santiago, Chile.
Patricia C GarcíaIniciativa Científica Milenio Para la Investigación Asociativa en Resistencia Antimicrobiana, MICROB-R, Santiago, Chile.
Juan A UgaldeIniciativa Científica Milenio Para la Investigación Asociativa en Resistencia Antimicrobiana, MICROB-R, Santiago, Chile.
Carlos J BlondelFacultad de Medicina y Facultad de Ciencias de la Vida, Instituto de Ciencias Biomédicas, Universidad Andrés Bello, Santiago, Chile.
Felipe LiraIFF - International Flavors and Fragrancies, CS 10010, 86220, Danger-Saint-Romain, France.
José Luis MartínezLaboratorio de Ecología y Evolución de la Resistencia a los Antibióticos, Departamento de Biotecnología Microbiana, Centro Nacional de Biotecnología, CNB, CSIC, Madrid, Spain.
Manuel Alcalde-RicoGrupo de Resistencia Antimicrobiana en Bacterias Patógenas y Ambientales, GRABPA, Instituto de Biología, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile. malcalde-ibis@us.es.ORCID http://orcid.org/0000-0002-1987-4600
Jorge Olivares-PachecoGrupo de Resistencia Antimicrobiana en Bacterias Patógenas y Ambientales, GRABPA, Instituto de Biología, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile. jorge.olivares@pucv.cl.ORCID http://orcid.org/0000-0002-6841-7182

Funding

Agencia Nacional de Investigación y Desarrollo FONDECYT 11150858
6 · The paper itself

Abstract

Pseudomonas gelidaquae IB20

Indexed as

BaysPseudomonasType III Secretion SystemsAntarctic RegionsBacterial ProteinsBacterial Typing TechniquesDNA, BacterialFatty AcidsGenome, BacterialIslandsPhylogenyRNA, Ribosomal, 16SBacterial ProteinsDNA, BacterialFatty AcidsRNA, Ribosomal, 16SType III Secretion SystemsAntarcticaKing George IslandPseudomonas gelidaquaeT3SSVopS effector protein

Identifiers

PMID40991091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.